title: Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis.
abstract: We report 2 cases of recurrent Campylobacter coli enteritis caused by macrolide- and fluoroquinolone-resistant strains in 2 patients with hypogammaglobulinemia, successfully treated with a prolonged course of fosfomycin-tromethamine with no side effects. Fosfomycin-tromethamine may be a feasible alternative therapy for recurrent enteritis caused by Campylobacter species resistant to first-line drugs.
authors.affiliation: Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain juanaguilarcompany@gmail.com cpigrau@vhebron.net.
authors.forename: Juan
authors.identifier: 0000-0002-9838-1950
authors.initials: J
authors.lastname: Aguilar-Company
authors.affiliation: Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Ibai
authors.identifier: 0000-0001-8835-2702
authors.initials: I
authors.lastname: Los-Arcos
authors.affiliation: Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015), Instituto de Salud Carlos III, Madrid, Spain juanaguilarcompany@gmail.com cpigrau@vhebron.net.
authors.forename: Carles
authors.initials: C
authors.lastname: Pigrau
authors.affiliation: Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015), Instituto de Salud Carlos III, Madrid, Spain.
authors.forename: Dolors
authors.initials: D
authors.lastname: Rodríguez-Pardo
authors.affiliation: Microbiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015), Instituto de Salud Carlos III, Madrid, Spain.
authors.forename: María Nieves
authors.initials: MN
authors.lastname: Larrosa
authors.affiliation: Microbiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015), Instituto de Salud Carlos III, Madrid, Spain.
authors.forename: Virginia
authors.initials: V
authors.lastname: Rodríguez-Garrido
authors.affiliation: Gastroenterology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Denisse
authors.initials: D
authors.lastname: Sihuay-Diburga
authors.affiliation: Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015), Instituto de Salud Carlos III, Madrid, Spain.
authors.forename: Benito
authors.initials: B
authors.lastname: Almirante
mesh_terms: D000361:Agammaglobulinemia / Q000188:drug therapy; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002167:Campylobacter / Q000187:drug effects* / Q000472:pathogenicity*; D004751:Enteritis / Q000188:drug therapy*; D005260:Female; D005578:Fosfomycin / Q000627:therapeutic use*; D006801:Humans; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D014325:Tromethamine / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D014325:Tromethamine; D005578:Fosfomycin